These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15705012)

  • 1. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.
    Iwasaki K; Satoh-Nakagawa T; Maruyama M; Monma Y; Nemoto M; Tomita N; Tanji H; Fujiwara H; Seki T; Fujii M; Arai H; Sasaki H
    J Clin Psychiatry; 2005 Feb; 66(2):248-52. PubMed ID: 15705012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.
    Shinno H; Inami Y; Inagaki T; Nakamura Y; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):881-5. PubMed ID: 18243460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.
    Mizukami K; Asada T; Kinoshita T; Tanaka K; Sonohara K; Nakai R; Yamaguchi K; Hanyu H; Kanaya K; Takao T; Okada M; Kudo S; Kotoku H; Iwakiri M; Kurita H; Miyamura T; Kawasaki Y; Omori K; Shiozaki K; Odawara T; Suzuki T; Yamada S; Nakamura Y; Toba K
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):191-9. PubMed ID: 19079814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled clinical trial of the Chinese herbal medicine "ba wei di huang wan" in the treatment of dementia.
    Iwasaki K; Kobayashi S; Chimura Y; Taguchi M; Inoue K; Cho S; Akiba T; Arai H; Cyong JC; Sasaki H
    J Am Geriatr Soc; 2004 Sep; 52(9):1518-21. PubMed ID: 15341554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
    Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
    Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.
    Furukawa K; Tomita N; Uematsu D; Okahara K; Shimada H; Ikeda M; Matsui T; Kozaki K; Fujii M; Ogawa T; Umegaki H; Urakami K; Nomura H; Kobayashi N; Nakanishi A; Washimi Y; Yonezawa H; Takahashi S; Kubota M; Wakutani Y; Ito D; Sasaki T; Matsubara E; Une K; Ishiki A; Yahagi Y; Shoji M; Sato H; Terayama Y; Kuzuya M; Araki N; Kodama M; Yamaguchi T; Arai H
    Geriatr Gerontol Int; 2017 Feb; 17(2):211-218. PubMed ID: 26711658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial.
    Nagata K; Yokoyama E; Yamazaki T; Takano D; Maeda T; Takahashi S; Terayama Y
    Phytomedicine; 2012 Apr; 19(6):524-8. PubMed ID: 22421528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with Yokukansan for behavioral and psychological symptoms of Parkinsonian dementia.
    Kawanabe T; Yoritaka A; Shimura H; Oizumi H; Tanaka S; Hattori N
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):284-7. PubMed ID: 19948198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashia M; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):150-4. PubMed ID: 17765378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Clin Neuropharmacol; 2009; 32(1):6-9. PubMed ID: 19471183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
    Okahara K; Ishida Y; Hayashi Y; Inoue T; Tsuruta K; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Yoshida K; Noda S; Tomita S; Fujimoto M; Hosomi J; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):532-6. PubMed ID: 20170698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y; Ishida Y; Inoue T; Udagawa M; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Sameshima T; Kawahara T; Goto I; Shudo K; Kurayama S; Nakamura J; Okahara K; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):541-5. PubMed ID: 20184936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yi-gan san for treatment of charles bonnet syndrome (visual hallucination due to vision loss): an open-label study.
    Miyaoka T; Furuya M; Kristian L; Wake R; Kawakami K; Nagahama M; Kawano K; Ieda M; Tsuchie K; Horiguchi J
    Clin Neuropharmacol; 2011; 34(1):24-7. PubMed ID: 21164340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
    Gu C; Shen T; An H; Yuan C; Zhou J; Ye Q; Liu T; Wang X; Zhang T
    Neurosci Lett; 2015 Oct; 606():13-7. PubMed ID: 26297124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavioral and psychological symptoms in elderly people with cognitive impairment. Differences between assessment at home and at an adult day-care facility].
    Hashidate H; Harada K; Asakawa Y; Yamagami T; Nihei K; Kaneya S; Yoshii C
    Nihon Koshu Eisei Zasshi; 2012 Aug; 59(8):532-43. PubMed ID: 23066632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Yi-Gan-san on the psychiatric behavior of children and adolescents with Tourette's Syndrome: A randomized, double-blind, controlled preliminary study.
    Huang CH; Liao WL; Lee DY; Chou IC; Wang MY; Hsieh CL
    J Ethnopharmacol; 2022 May; 290():115098. PubMed ID: 35182665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine.
    Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Takayama S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
    Psychogeriatrics; 2012 Dec; 12(4):235-41. PubMed ID: 23279145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.